Theragenics Corporation is a medical device company operating two business segments: surgical products and cancer treatment. Its surgical offerings include wound closure, vascular access, and specialty needle products. Besides, the company manufactures and markets low-dose-rate (LDR) brachytherapy seeds for the treatment of prostate cancer, lung cancer, intra-ocular malignancies, Benign disease, and other solid tumors.